(77 days)
Not Found
No
The device description and performance studies focus on chemical reactions and standard statistical analysis, with no mention of AI or ML terms or concepts.
No.
This device is an in vitro diagnostic product designed for quantitative determination of HDL cholesterol, not for therapeutic purposes.
Yes
The device "is an in vitro diagnostic product" for the quantitative determination of HDL cholesterol in human serum or plasma, which is used for diagnostic purposes in a clinical laboratory setting.
No
The device description clearly states it is an "in vitro diagnostic product" and describes chemical reagents and their interactions with biological samples, indicating it is a hardware-based diagnostic kit, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use / Indications for Use: The document explicitly states "For in vitro diagnostic use" multiple times in the intended use section.
- Device Description: The description refers to the kit as "an in vitro diagnostic product".
- FDA Clearance: It mentions FDA clearance with a reference number (K962186), which is a process for IVD devices.
N/A
Intended Use / Indications for Use
for the quantitative determination of high density lipoprotein (HDL) cholesterol in human serum or plasma.
For in vitro diagnostic use.
For the calibration of N-geneous HDL Cholesterol ass in serum or plasma. For in vitro diagnostic use.
Product codes
LBS, JIS
Device Description
The Genzyme N-geneous™ HDL Cholesterol Kit is a homogenous assay applicable to clinical chemistry analyzers that can accomodate two-reagent systems and does not require any off-line sample pretreatment or centrifugation steps.
The first reagent contains a mixture of polymers and polyanions that bind to the surface of low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and chylomicrons. These complexed lipoproteins are stabilized, even in the presence of detergent which is added as part of the second reagent, together with the remaining components of a cholesterol reagent. HDL particles, on the other hand, are not stabilized by the polymers and polyanions and become solubilized by the detergent. Consequently, only the HDL cholesterol is subject to cholesterol measurement.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physician's office laboratory, clinical laboratory
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Comparative performance studies: Three physician office laboratories (POL) analyzed 40 serum samples using the N-geneous™ HDL Cholesterol Reagent Kit. Split samples from the same 40 specimens were also analyzed at Genzyme, which acted as the reference laboratory. In the same study, the three POL sites compared their Genzyme N-geneous™ HDL Cholesterol Reagent Kit results to their respective current Sodium Phosphotungstate MgCly method (PTA) for each of these 40 patient samples.
Precision studies: Both within-run and between-run studies were performed using frozen serum pools at three target levels of HDL cholesterol as determined by the National Cholesterol Education Program (NCEP): 60 mg/dL (high).
Key results: The correlation coefficient between the reference testing site and the POL testing sites for the 40 serum samples ranged from 0.97 to 0.99. The correlation coefficients for the comparison between the N-geneous™ HDL Cholesterol Reagent Kit and the Sodium Phosphotungstate MgCl2 method ranged from 0.97 to 0.99. It was determined that each POL site achieved the NCEP goals of CVs ≤6% at ≥42 mg/dL, and ≤2.5 mg/dL SD at
§ 862.1475 Lipoprotein test system.
(a)
Identification. A lipoprotein test system is a device intended to measure lipoprotein in serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
0
510(k) PREMARKET NOTIFICATION
-geneous™ HDL Cholesterol
Reagent Kit
March 28, 1997
ATTACHMENT 1
510(k) Summary Of Safety and Effectiveness Information Upon Which An Equivalence Determination Could be Made
Trade or Proprietary Name: | Genzyme N-geneous™ HDL Cholesterol Kit |
---|---|
Common or Usual Name: | Homogeneous assay for high density lipoprotein cholesterol |
Classification Name: | High density lipoprotein cholesterol test |
Manufacturer: | Genzyme Diagnostics |
One Kendall Square | |
Cambridge, MA 02139-1562 | |
Contact Person: | Nancy E. Isaac, Associate Director, Regulatory Affairs (617) 374-7431 or |
The use of the Genzyme N-geneous™ HDL Cholesterol Kit in the physician's office laboratory setting is substantially equivalent to the N-geneous™ HDL Cholesterol Kit when used in a clinical laboratory. The Genzyme N-geneous™ HDL Cholesterol Kit is an in vitro diagnostic product cleared (FDA Reference No. K962186) for use in the clinical laboratory for the quantitative determination of high density lipoprotein cholesterol in human serum or plasma. The present clinical laboratory setting is
Beth A. Crowlev, Requlatory Associate (617) 252-7669.
In both user settings, the Genzyme N-geneous™ HDL Cholesterol Kit is a homogenous assay applicable to clinical chemistry analyzers that can accomodate two-reagent systems and does not require any off-line sample pretreatment or centrifugation steps.
being expanded to include physician office laboratories.
The first reagent contains a mixture of polymers and polyanions that bind to the surface of low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and chylomicrons. These complexed lipoproteins are stabilized, even in the presence of detergent which is added as part of the second reagent, together with the remaining components of a cholesterol reagent. HDL particles, on the other hand, are not stabilized by the polymers and polyanions and become solubilized by the detergent. Consequently, only the HDL cholesterol is subject to cholesterol measurement.
In comparative performance studies, three physician office laboratories (POL) analyzed 40 serum samples using the N-geneous™ HDL Cholesterol Reagent Kit. Split samples from the same 40 specimens were also analyzed at Genzyme, which acted as the reference laboratory. The correlation coefficient between the reference testing site and the POL testing sites for this study were:
1
510(k) PREMARKET NOTIFICATION
| A N A SE SEN RESER E L L BELL MODEL COLLECTION CONNUME
11. SELLER I LENSION LAND LAND SERVICE FOR CONNECT FOR CONNUMER FOR CONNUMBER 1 FOR CONSULTION CONNUMBER 1 FOR CONSULTION CONNUMBER 1 COLLEGION COLLEGION COLLEGION COLLEGION
-arameter
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------- | of the differ the results of the first and the consisted announce and consisted and the commend consisted to commend and the commend and the commend of the commend the commen
CONSULT & FACTORIAL COLLECTION OF CLAIMS OF | |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---|
| Slobe | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | .
AND RANKE | |
| Intercent | | CONTRACT MILLERS CLA | . |
| money of the country to comprehensive the only of the color of the color of the color of the commend to the first and the commend to the first and the commend to the first an
Correlation (
Coetticient (r) |
---|
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
In the same study, the three POL sites compared their Genzyme N-geneous™ HDL Cholesterol Reagent Kit results to their respective current Sodium Phosphotungstate MgCly method (PTA) for each of these 40 patient samples. The correlation coefficient for these comparisons were:
Parameter | Site #1 | Site #2 | Site #3 |
---|---|---|---|
Slope | 0.88 | 1.05 | 0.77 |
Intercept (mg/dL) | 2.90 | -1.32 | 11.1 |
Correlation Coefficient (r) | 0.97 | 0.99 | 0.98 |
Precision studies were conducted using the N-geneous™ HDL Cholesterol Test Kit. Both within-run and between-run studies were performed using frozen serum pools at three target levels of HDL cholesterol as determined by the National Cholesterol Education Program (NCEP): 60 mg/dL (high). It was determined that each POL site achieved the NCEP goals of CVs ≤6% at ≥42 mg/dL, and ≤2.5 mg/dL SD at